Respiratory Illness News and Research

RSS

Long COVID manifests as a post-viral syndrome indistinguishable from other respiratory illnesses

Long COVID appears to manifest as a post-viral syndrome indistinguishable from seasonal influenza and other respiratory illnesses, with no evidence of increased moderate-to-severe functional limitations a year after infection, according to new research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).

14 Mar 2024

New collaboration launched to support the development of vaccines against henipavirus

A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against henipavirus - a genus (or group) of viruses including Nipah virus.

13 Mar 2024

Research uncovers mechanical explanation for instability in the lungs of ARDS patients

Researchers at the University of Minnesota Twin Cities may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.

12 Mar 2024

Nirsevimab shows 90% success in shielding infants from RSV hospitalizations

Study demonstrated a 90% effectiveness of nirsevimab in preventing RSV-associated hospitalizations in infants, with a significant finding being the timely vaccination's role in offering protection.

10 Mar 2024

CDC studies show effectiveness of flu vaccines across all age groups

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

19 Feb 2024

Has a decade of maternal pertussis vaccination reduced its effectiveness?

Research indicates maternal immunization against pertussis remains crucial for newborn protection despite concerns of reduced vaccine effectiveness over time, underscoring its vital role in preventing infant mortality.

3 Feb 2024

Universal consensus definition unlocks research advancements for critically ill children worldwide

St. Jude Children's Research Hospital investigators collaborated with a global group of acute pediatric critical illness experts to reach a consensus definition of the condition.

9 Jan 2024

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

It's winter, that cozy season that brings crackling fireplaces, indoor gatherings — and a wave of respiratory illness.

8 Jan 2024

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

The UK Health Security Agency (UKHSA) is reminding all those eligible that it's not too late to book their flu and COVID-19 vaccinations.

5 Jan 2024

Vaccination encouraged for eligible groups as flu cases spike

All those eligible for the flu vaccine are being urged to come forward as the UK Health Security Agency (UKHSA) published data showing a significant increase in the number of recorded flu cases.

15 Dec 2023

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Study suggests non-prescription sales data can help to forecast respiratory disease fatalities

Researchers investigated the value of integrating sales of non-prescription medications (e.g., cough syrups) for improved forecasting of deaths from respiratory diseases in England using artificial intelligence (AI)-based predictive tools.

23 Nov 2023

Sales of respiratory medications key to predicting disease mortality, UK study finds

The value of integrating national longitudinal shopping data into respiratory disease forecasting models.

22 Nov 2023

Elderly and vulnerable people at risk from low home temperatures, warns Lilli

Interventions are needed to urgently prevent elderly and vulnerable people from putting their health at risk, with temperatures inside some homes reaching as low as 5C last winter, says Lilli, the SaaS company using a proactive care lifestyle monitoring technology to revolutionise care.

12 Oct 2023

Obese adults with ARDS may benefit from ECMO

A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation (ECMO), an advanced form of breathing support, when in intensive care for respiratory failure.

28 Aug 2023

Timing and cost of new vaccines vary by virus and health insurance status

As summer edges toward fall, thoughts turn to, well, vaccines.

24 Aug 2023

New study untied taste from smell in people with COVID-19

Smell loss became the cardinal symptom of COVID-19 early in the pandemic and has ignited research on how smell and taste function. An international study led by the Global Consortium for Chemosensory Research (GCCR) and the Monell Chemical Senses Center has untied taste from smell in people with COVID-19, demonstrating in a large and diverse group of more than 10,000 people that taste, independent of smell, is also greatly impacted by COVID. The team recently published their findings in Chemical Senses.

18 Aug 2023

Study explores the protective effect of transmembrane mucins against SARS-CoV-2 infection

A recent study analyzed the role played by host mucins and mucin glycans with regard to SARS-CoV-2 entry into the airway epithelial cells.

15 Aug 2023

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023